Tuoxin Pharmaceutical Group Co., Ltd. (301089.SZ) Subsidiary's Product, Glyceryl Phosphoryl Choline, Achieves Self-GRAS Status in the US

Stock News10-17

Tuoxin Pharmaceutical Group Co., Ltd. (301089.SZ) announced that its wholly-owned subsidiary, Xinxiang Jingquan Biotechnology Co., Ltd. (referred to as “Jingquan Biotechnology”), has successfully obtained Self-GRAS status for its product, Glyceryl Phosphoryl Choline, after a rigorous scientific evaluation in accordance with the U.S. Food and Drug Administration's (FDA) Generally Recognized As Safe (GRAS) criteria. The announcement highlights that Glyceryl Phosphoryl Choline is a naturally occurring choline compound in the human body and a key component of brain nerve cell membranes. As a highly bioavailable source of choline, its core benefits have been validated through extensive research, specifically including: enhancing cognitive function, supporting normal brain operations to maintain brain health, improving athletic performance and post-exercise recovery, as well as providing neuroprotection to ensure the health of the nervous system.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180038410?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-17 17:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180038410","market":"us","top_or_hot":-1,"title":"Tuoxin Pharmaceutical Group Co., Ltd. (301089.SZ) Subsidiary's Product, Glyceryl Phosphoryl Choline, Achieves Self-GRAS Status in the US","media":"Stock News","content":"<p>Tuoxin Pharmaceutical Group Co., Ltd. (301089.SZ) announced that its wholly-owned subsidiary, Xinxiang Jingquan Biotechnology Co., Ltd. (referred to as “Jingquan Biotechnology”), has successfully obtained Self-GRAS status for its product, Glyceryl Phosphoryl Choline, after a rigorous scientific evaluation in accordance with the U.S. Food and Drug Administration's (FDA) Generally Recognized As Safe (GRAS) criteria. The announcement highlights that Glyceryl Phosphoryl Choline is a naturally occurring choline compound in the human body and a key component of brain nerve cell membranes. As a highly bioavailable source of choline, its core benefits have been validated through extensive research, specifically including: enhancing cognitive function, supporting normal brain operations to maintain brain health, improving athletic performance and post-exercise recovery, as well as providing neuroprotection to ensure the health of the nervous system.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tuoxin Pharmaceutical Group Co., Ltd. (301089.SZ) Subsidiary's Product, Glyceryl Phosphoryl Choline, Achieves Self-GRAS Status in the US</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTuoxin Pharmaceutical Group Co., Ltd. (301089.SZ) Subsidiary's Product, Glyceryl Phosphoryl Choline, Achieves Self-GRAS Status in the US\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-10-17 17:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tuoxin Pharmaceutical Group Co., Ltd. (301089.SZ) announced that its wholly-owned subsidiary, Xinxiang Jingquan Biotechnology Co., Ltd. (referred to as “Jingquan Biotechnology”), has successfully obtained Self-GRAS status for its product, Glyceryl Phosphoryl Choline, after a rigorous scientific evaluation in accordance with the U.S. Food and Drug Administration's (FDA) Generally Recognized As Safe (GRAS) criteria. The announcement highlights that Glyceryl Phosphoryl Choline is a naturally occurring choline compound in the human body and a key component of brain nerve cell membranes. As a highly bioavailable source of choline, its core benefits have been validated through extensive research, specifically including: enhancing cognitive function, supporting normal brain operations to maintain brain health, improving athletic performance and post-exercise recovery, as well as providing neuroprotection to ensure the health of the nervous system.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"","article_id":"1180038410","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180038410","pubTimestamp":1760691860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Tuoxin Pharmaceutical Group Co., Ltd. (301089.SZ) announced that its wholly-owned subsidiary, Xinxiang Jingquan Biotechnology Co., Ltd. (referred to as “Jingquan Biotechnology”), has successfully...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"301089":"拓新药业","BK0239":"医药制造"},"translate_title":"拓新药业集团股份有限公司（301089.SZ）子公司产品甘油磷酰胆碱在美国获得自我GRAS地位","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"301089":1},"content_text":"Tuoxin Pharmaceutical Group Co., Ltd. (301089.SZ) announced that its wholly-owned subsidiary, Xinxiang Jingquan Biotechnology Co., Ltd. (referred to as “Jingquan Biotechnology”), has successfully obtained Self-GRAS status for its product, Glyceryl Phosphoryl Choline, after a rigorous scientific evaluation in accordance with the U.S. Food and Drug Administration's (FDA) Generally Recognized As Safe (GRAS) criteria. The announcement highlights that Glyceryl Phosphoryl Choline is a naturally occurring choline compound in the human body and a key component of brain nerve cell membranes. As a highly bioavailable source of choline, its core benefits have been validated through extensive research, specifically including: enhancing cognitive function, supporting normal brain operations to maintain brain health, improving athletic performance and post-exercise recovery, as well as providing neuroprotection to ensure the health of the nervous system.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180038410","isCrawlerRequest":true}